Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 338

Results For "SSI"

5634 News Found

Keytruda + chemotherapy improved overall survival versus chemotherapy alone as for advanced malignant pleural mesothelioma
Clinical Trials | March 12, 2023

Keytruda + chemotherapy improved overall survival versus chemotherapy alone as for advanced malignant pleural mesothelioma

For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma


USFDA completes inspection of Lupin’s Vizag facility
Drug Approval | March 11, 2023

USFDA completes inspection of Lupin’s Vizag facility

The inspection concluded with no observations


Baxter launches the 'Choose Freedom' campaign for kidney disease patients
Healthcare | March 11, 2023

Baxter launches the 'Choose Freedom' campaign for kidney disease patients

Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.


IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases
News | March 11, 2023

IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases

IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases


Zydus receives final approval from the USFDA for Erythromycin Tablets
Drug Approval | March 10, 2023

Zydus receives final approval from the USFDA for Erythromycin Tablets

Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body


Atlas Copco acquires FS Medical’s medical gas systems
News | March 10, 2023

Atlas Copco acquires FS Medical’s medical gas systems

The business serves the healthcare and laboratory sectors on the west coast of the United States.


SRL Diagnostics partners with PathPresenter to enable digital pathology consultations
Clinical Trials | March 10, 2023

SRL Diagnostics partners with PathPresenter to enable digital pathology consultations

This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images


Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility
Drug Approval | March 09, 2023

Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility

Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)


Lonza upgrades powder characterization capabilities at Tampa
News | March 09, 2023

Lonza upgrades powder characterization capabilities at Tampa

The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation